Universita' Cattolica del Sacro Cuore
Also known as: Fondazione Policlinico A. Gemelli IRCCS | Fondazione Policlinico Agostino Gemelli IRCCS | Fondazione Policlinico Gemelli IRCCS | Fondazione Policlinico Universitario A. Gemelli, IRCCS | Fondazione Policlinico Universitario A. Gemelli IRCCS; Università Cattolica del Sacro Cuore | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Policlinico Universitario Agostino Gemelli Università Cattolica del Sacro Cuore | Unit for Hematology and BMT, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy | University Cattolica del Sacro Cuore Roma Italy | Universtita' Cattolica del Sacro Cuore | Universtita' Cattolica del Sacro Cuore, Dipartimento di Oncologia - Roma, Italy
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2006Last known activity
Jan 7, 2025
Timeline
1920s
- Dec 7, 1921
Universita' Cattolica del Sacro Cuore— Founded
Drugs by trial phase (80 distinct, 61 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Indications
Studied for
- Anterior Wall Myocardial Infarction
- Carcinoma, Ovarian Epithelial
- Disease Progression
- Fallopian Tube Neoplasms
- Infarction
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Myocardial Infarction
- Ovarian Neoplasms
- Preleukemia
- Pulmonary Valve Insufficiency
- Respiratory Insufficiency
- Retinitis
- Retinitis Pigmentosa
- Sinusitis
- Uterine Cervical Neoplasms
Recent trials (50)
- NCT06820255Lead sponsorPhase 4Jan 7, 2025
- NCT06820255OfficialPhase 4Jan 7, 2025
- NCT06959979Sponsor investigatorEarly Phase 1Nov 25, 2024
- NCT06959979Lead sponsorEarly Phase 1Nov 25, 2024
- NCT06640166Lead sponsorPhase 2Jun 3, 2024
- NCT06640166OfficialPhase 2Jun 3, 2024
- NCT06865261OfficialN/AMay 20, 2024
- NCT06865261Lead sponsorN/AMay 20, 2024
- NCT06283381Lead sponsorPhase 4Feb 1, 2024
- NCT06071312Overall official - principal investigatorPhase 1/Phase 2Sep 23, 2023
- NCT06071312Lead sponsorPhase 1/Phase 2Sep 23, 2023
- NCT06071312Reponsible party - principal investigatorPhase 1/Phase 2Sep 23, 2023
- NCT05970770Lead sponsorPhase 4Sep 1, 2023
- NCT05835882Overall official - principal investigatorN/AJun 1, 2023
- NCT05835882Lead sponsorN/AJun 1, 2023
Details
- Founded
- Milan, IT Dec 7, 1921
- Last known activity
- Jan 7, 2025